PRGO
Perrigo Co. Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$15.66
−0.32%Price chart
Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3Nov 6
Key dataNov 6, 2026
Open$15.50
From 52W high−5.83%
Volume303038.00
Market cap$2.17B
P/E (TTM)—
P/S (TTM)0.5x
Div yield7.41%
Key dataNov 6, 2026
Open
$15.50
From 52W high
−5.83%
Volume
303038.00
Market cap
$2.17B
ValuationView details →
P/E (Fwd)
6.3x
EV/EBITDA
−4.5x
P/E (TTM)
—
RSI (14)
52.7
MomentumView details →
1D Return
−0.32%
YTD Return
+12.43%
SummaryUpdated Sep 1, 2026
Perrigo Company plc (NYSE:PRGO) is a Dublin-based consumer healthcare company founded in 1887 that has evolved from a small Michigan pharmacy into a global leader in over-the-counter health and wellness products. The company operates as one of the world's largest manufacturers of store-brand consumer healthcare products, serving both retail chains and consumers directly through its own branded products. Perrigo has undergone significant transformation in recent years, divesting its prescription pharmaceuticals business to focus exclusively on consumer self-care products across the Americas and international markets.
Similar companies
Latest newsMore news →
PERRIGO Co plc reported quarterly earnings of $0.60 per share, compared with $0.80 per share a year earlier.2d agoPERRIGO Co plc reported third-quarter net sales of $988.6 million.2d agoPerrigo updated its full-year 2026 outlook to reflect the Infant Formula divestiture, more measured retailer inventory positioning, and continued softness in Europe.2d ago